SEC Tracker
Get the app

Homology Medicines QTTB

The Homology board of directors approved a reverse stock split ratio of 1-for-18, such

Form
8-K/A
Filed
Period
Importance
Routine
Document
8-K/A
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Homology Medicines files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Kiora Pharmaceuticals KPRX public float $10M, Jun 30, 2025
  2. Brainstorm Cell Therapeutics BCLI public float $10M, Jun 30, 2025
  3. Scienture Holdings SCNX public float $10M, Jun 30, 2025
  4. LeonaBio ATHA public float $10M, Jun 30, 2025
  5. Mannatech MTEX public float $10M, Jun 30, 2025